Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carl Feldbaum Insider Profile
4 Followers
Carl Feldbaum, Director at Exelixis, holds 18.70K shares in Exelixis (Ticker: EXEL), holds 0.00 shares in Cardiff Oncology (Ticker: CRDF). Most recently, Carl Feldbaum Sold ― shares of Exelixis on Feb 10, 2023 for an estimated value of 711.20K.
Profitable Transactions
8 out of 12 Profitable Transactions
Average Return
-3.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Carl Feldbaum
Carl Feldbaum's Trading History
Exelixis
Feb 10, 2023
Director
Informative Sell
711.20K
$399.64K
Cardiff Oncology
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Carl Feldbaum's performance on stock
You May Also Like
Carl Feldbaum insider profile FAQ
What is the percentage of profitable transactions made by Carl Feldbaum?
The percentage of profitable transactions made by Carl Feldbaum is 67%.
What is the average return per transaction made by Carl Feldbaum?
The average return per transaction made by Carl Feldbaum is -3.30%.
What stocks does Carl Feldbaum hold?
Carl Feldbaum holds: EXEL, CRDF stocks.
What was Carl Feldbaum’s latest transaction?
Carl Feldbaum latest transaction was an Informative Sell of $711.20K.
What was Carl Feldbaum's most profitable transaction?
Carl Feldbaum’s most profitable transaction was an Informative Sell of EXEL stock on February 17, 2021. The return on the trade was 19.70%.
What is Carl Feldbaum's role in Exelixis?
Carl Feldbaum's role in Exelixis is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.